Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 19, 2011

Premium

Geoffrey Crouse has resigned as chief operating officer at Immucor. Prior to joining Immucor in 2009, Crouse served as vice president of Millipore's life sciences business.


Rosetta Genomics has tapped Brian Markison as chairman of the board. He will replace Yoay Chelouche, who resigned from the post.

Markison formerly was CEO and chairman of King Pharmaceuticals. Chelouche will continue to serve as chairman of Rosetta Green, the firm's majority-held plant biotechnology subsidiary


The American College of Medical Genetics Foundation has named six new members to serve on its board of directors. The new ACMG Foundation directors include Thomas Erickson, co-founder and partner of BlueStream Ventures; Gail Herman, ACMG's president-elect and a principal investigator at the Center for Molecular and Human Genetics and a professor at Ohio State University; Rick Martin, medical director of Shire Human Genetic Therapies of Cambridge, UK; Lisa Shaffer, president of Signature Genomics; Brian Ward, COO of On-Q-ity; and Judy Yu, associate director of scientific affairs, global marketing for Abbott Molecular.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.